Challenges of establishing new antithrombotic therapies in atrial fibrillation

被引：69

作者：

Connolly, Stuart J. ^{[1
]}

Eikelboom, John ^{[1
]}

O'Donnell, Martin ^{[1
]}

Pogue, Janice ^{[1
]}

Yusuf, Salim ^{[1
]}

机构：

[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada

来源：

CIRCULATION | 2007年 / 116卷 / 04期

关键词：

D O I：

10.1161/CIRCULATIONAHA.107.695163

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：449 / 455

页数：7

共 35 条

[1]

Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690

[2]

Albers GW, 2003, LANCET, V362, P1691

[3]

[Anonymous], 2001, CIRCULATION, V104, P2118

[4]

[Anonymous], 1997, Arch Intern Med, V157, P1237

[5] Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation [J].

Birman-Deych, E ;

Radford, MJ ;

Nilasena, DS ;

Gage, BF .

STROKE, 2006, 37 (04) :1070-1074

[6]

Blackshear JL, 1996, LANCET, V348, P633

[7] An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committees [J].

Brown, David ;

Volkers, Peter ;

Day, Simon .

STATISTICS IN MEDICINE, 2006, 25 (10) :1623-1627

[8] Why do patients with atrial fibrillation not receive warfarin? [J].

Bungard, TJ ;

Ghali, WA ;

Teo, KK ;

McAlister, FA ;

Tsuyuki, RT .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :41-46

[9] The belgian improvement study on oral anticoagulation therapy: a randomized clinical trial [J].

Claes, N ;

Buntinx, F ;

Vijgen, J ;

Arnout, J ;

Vermylen, J ;

Fieuws, S ;

Van Loon, H .

EUROPEAN HEART JOURNAL, 2005, 26 (20) :2159-2165

[10] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].

Connolly, S. ;

Pogue, J. ;

Hart, R. ;

Pfeffer, M. ;

Hohnloser, S. ;

Chrolavicius, S. ;

Yusuf, S. .

LANCET, 2006, 367 (9526) :1903-1912

← 1 2 3 4 →